E. Vrentzos

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial

H. Milionis, E. Michelakis, E. Giamarellos‐Bourboulis, 2021, Infectious Diseases and Therapy.

Covid Visual Assessment Scale (“Co.V.A.Sc.”): quantification of COVID-19 disease extent on admission chest computed tomography (CT) in the prediction of clinical outcome—a retrospective analysis of 273 patients

S. Spiliopoulos, N. Kelekis, K. Palialexis, 2022, Emergency Radiology.

Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label trial

H. Milionis, E. Michelakis, E. Giamarellos‐Bourboulis, 2020 .

Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators

K. Syrigos, H. Milionis, E. Michelakis, 2020, medRxiv.

In‐hospital falls in older patients: A prospective study at the University Hospital of Heraklion, Crete, Greece

G. Samonis, K. Alpantaki, C. Koutserimpas, 2016, Australasian journal on ageing.

Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19)

M. Saridaki, E. Giamarellos‐Bourboulis, S. Metallidis, 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.